|
Beurs gesloten -
London S.E.
17:35:29 11-09-2026
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
| 11.708,00 GBX | -0,43% |
|
-2,48% | -15,10% |
| 11/09 | AstraZeneca meldt dat laatstefasestudie met Etcamah tegen borstkanker hoofddoel niet heeft behaald | MT |
| 11/09 | Borstkankerpil van AstraZeneca stelt teleur in laatstefasestudie | RE |
Belangrijkste concurrenten
Toevoegen aan een lijst 0 geselecteerde | Verschil (%) | Varia. 5d. | Evolutie 1 maand | Evolutie 3 maanden | Var. 1 jan | Varia. 1j. | Varia. 3j. | Varia. 5j. | Varia. 10j. | Kap.($) | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -0,43% | -2,48% | -1,15% | -13,77% | -15,10% | -2,07% | +11,48% | +43,25% | +142,95% | 246 mld. | |
| -0,65% | -2,93% | -8,17% | -3,90% | +3,82% | +47,52% | +87,34% | +365,85% | +1.326,00% | 994 mld. | |
| -0,29% | -3,51% | +2,22% | +11,43% | +28,33% | +48,78% | +63,27% | +59,06% | +124,63% | 640 mld. | |
| +0,83% | +0,26% | +2,81% | +14,39% | +12,53% | +16,76% | +72,52% | +141,02% | +305,81% | 454 mld. | |
| -0,38% | -3,59% | -6,70% | +5,81% | +4,88% | +28,24% | +35,57% | +0,06% | +43,42% | 337 mld. | |
| -0,09% | -13,54% | -10,98% | -7,82% | +2,23% | +10,08% | +26,87% | +42,42% | +44,75% | 261 mld. | |
| -1,34% | -13,70% | -8,92% | +6,58% | +15,29% | +33,47% | +44,18% | +76,54% | +126,57% | 204 mld. | |
| -3,44% | -7,51% | -10,01% | -2,16% | -15,00% | -20,08% | -59,58% | -11,89% | +86,73% | 190 mld. | |
| -0,75% | -4,82% | +5,86% | +14,18% | +17,09% | +21,94% | +86,55% | +102,45% | +84,14% | 178 mld. | |
| +0,25% | -2,57% | +4,13% | +5,92% | +11,33% | +11,50% | -18,33% | -39,20% | -18,71% | 158 mld. | |
| +0,17% | -5,62% | -2,68% | +15,82% | +13,69% | +29,71% | +48,45% | +173,34% | +450,21% | 131 mld. | |
| -0,17% | -4,76% | +0,05% | +11,85% | +17,98% | +33,87% | +4,65% | +0,81% | +14,34% | 130 mld. | |
| -0,42% | -3,93% | -2,84% | -3,98% | -11,44% | -9,26% | -28,05% | -10,52% | +4,14% | 102 mld. | |
| -0,28% | -4,12% | -6,62% | -9,78% | -2,96% | +16,67% | +20,54% | -0,23% | -11,45% | 95,94 mld. | |
| +0,06% | -5,49% | -9,70% | -13,54% | -22,09% | -3,37% | +43,44% | +53,82% | +462,51% | 68,8 mld. | |
| +0,16% | -1,51% | +1,50% | +12,58% | +17,19% | +25,80% | +24,66% | +51,05% | +20,30% | 58,91 mld. | |
| -1,09% | -1,39% | -1,59% | +34,59% | +30,15% | +67,08% | -5,92% | +5,23% | -49,31% | 54,92 mld. | |
| +2,04% | +2,01% | +1,67% | +7,32% | +18,84% | +86,48% | +269,42% | +303,59% | -26,13% | 43,22 mld. | |
| -0,61% | -7,28% | -22,38% | -9,17% | -28,37% | -37,52% | -0,77% | -10,07% | +166,26% | 41,9 mld. | |
| -0,71% | -5,39% | -8,65% | -0,06% | -10,94% | -8,32% | +2,77% | - | - | 39,76 mld. | |
| Gemiddelde | -0,33% | -4,76% | -4,11% | +3,81% | +4,37% | +19,86% | +36,45% | +70,87% | +173,53% | 221,44 mld. | |
| Gewogen gemiddelde per kap. | -0,39% | -4,32% | -3,61% | +3,34% | +7,74% | +27,60% | +48,38% | +126,27% | +398,57% |
Kies jouw editie
Alle financiële informatie op nationaal niveau
